Aileron Therapeutics Inc (ALRN)
3.76
-0.06
(-1.57%)
USD |
NASDAQ |
May 03, 16:00
3.76
0.00 (0.00%)
Pre-Market: 20:00
Aileron Therapeutics Total Assets (Quarterly): 106.01M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.01M |
| September 30, 2023 | 12.82M |
| June 30, 2023 | 13.99M |
| March 31, 2023 | 17.16M |
| December 31, 2022 | 22.01M |
| September 30, 2022 | 27.23M |
| June 30, 2022 | 33.77M |
| March 31, 2022 | 40.26M |
| December 31, 2021 | 48.48M |
| September 30, 2021 | 54.77M |
| June 30, 2021 | 60.53M |
| March 31, 2021 | 64.67M |
| December 31, 2020 | 16.34M |
| September 30, 2020 | 22.24M |
| June 30, 2020 | 26.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.37M |
| December 31, 2019 | 26.47M |
| September 30, 2019 | 33.95M |
| June 30, 2019 | 40.19M |
| March 31, 2019 | 22.40M |
| December 31, 2018 | 30.31M |
| September 30, 2018 | 38.13M |
| June 30, 2018 | 42.58M |
| March 31, 2018 | 45.83M |
| December 31, 2017 | 52.69M |
| September 30, 2017 | 59.04M |
| June 30, 2017 | 15.10M |
| March 31, 2017 | 17.16M |
| December 31, 2016 | 22.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.82M
Minimum
Sep 2023
106.01M
Maximum
Dec 2023
36.18M
Average
27.23M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 355.18M |
| INVO Bioscience Inc | 20.89M |
| Bio-Path Holdings Inc | 3.22M |
| SINTX Technologies Inc | 15.36M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 99.12M |
| Shareholders Equity (Quarterly) | 6.887M |